2017 Annual Meeting | C122 - Neurology Update III: Neuromuscular, Dementia, and Stroke

Date Tuesday 04/25/17

Time 01:00 PM - 03:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Barney J. Stern, MD, F�鶹��ýӳ��

Topic(s) General Neurology

Learning Objectives Participants should be able to be aware of the current developments in the diagnosis, management, and treatment of patients with stroke, neuromuscular disorders, and dementia and be able to put recent developments in context to provide optimal patient care.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Didactic

Event Timeline
01:00 PM - 01:40 PM	Speaker	Neuromuscular Disorders Justin Y. Kwan, MD, F�鶹��ýӳ��
01:40 PM - 02:20 PM	Speaker	Dementia Gregory S. Day, MD, MSc, F�鶹��ýӳ��
02:20 PM - 03:00 PM	Speaker	Stroke Scott B. Silverman, MD

Faculty Disclosures
Justin Y. Kwan, MD, F�鶹��ýӳ��	Dr. Kwan has received research support from National Institutes of Health. Dr. Kwan has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with National Institutes of Health.
Gregory S. Day, MD, MSc, F�鶹��ýӳ��	Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with �鶹��ýӳ��. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing �鶹��ýӳ��, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a �鶹��ýӳ��al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to �鶹��ýӳ�� interests or activities.
Scott B. Silverman, MD	Dr. Silverman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law Firms.
Barney J. Stern, MD, F�鶹��ýӳ��	Dr. Stern has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Foundation for Sarcoidosis Research. The institution of Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. Dr. Stern has received publishing royalties from a publication relating to health care.